artemisinin has been researched along with Disease Models, Animal in 48 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (6.25) | 18.2507 |
2000's | 5 (10.42) | 29.6817 |
2010's | 27 (56.25) | 24.3611 |
2020's | 13 (27.08) | 2.80 |
Authors | Studies |
---|---|
Avery, VM; Baragaña, B; Campbell, SF; Delves, MJ; Duffy, S; Fairlamb, AH; Frearson, JA; Gilbert, IH; Gray, DW; Grimaldi, R; Hallyburton, I; Meister, S; Norcross, NR; Norval, S; Osuna-Cabello, M; Porzelle, A; Read, KD; Riley, J; Simeons, FR; Sinden, RE; Stojanovski, L; Waterson, D; Willis, P; Wilson, C; Winzeler, EA; Wittlin, S; Wyatt, PG | 1 |
Avery, VM; Baell, JB; Bullen, HE; Cowman, AF; Crabb, BS; Curtis, JM; Di Rago, AE; Duffy, S; Gilson, PR; Hutton, CA; Jarman, KE; Jousset Subroux, H; Lowes, KN; Nguyen, W; Prinz, B; Sleebs, BE; Tan, C | 1 |
Bordignon, A; Cieckiewicz, E; Di Giovanni, N; Frédérich, M; Hoareau, F; Illien, B; Jansen, O; Ledoux, A; Marvilliers, A; Pendeville, H; Quetin-Leclercq, J; St-Gelais, A | 1 |
Adah, D; Chen, X; Dai, L; Goldberg, DE; Guan, J; Leng, F; Li, X; Liu, J; Liu, X; Liu, Z; Lu, Y; Ma, H; McNitt, SA; Meyers, MJ; Nasamu, AS; Polino, AJ; Qin, L; Tortorella, MD; Tu, Z; Xu, J; Zhao, S | 1 |
Faist, J; Hochegger, P; Kaiser, M; Mäser, P; Saf, R; Seebacher, W; Weis, R | 1 |
Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
Amanzougaghene, N; Ashraf, K; Azas, N; Benoit-Vical, F; Bosson-Vanga, H; Cohen, A; Dereuddre-Bosquet, N; Donnette, M; Franetich, JF; Gomez, L; Hutter, S; Lagardère, P; Lavazec, C; Le Grand, R; Lisowski, V; Malzert-Fréon, A; Masurier, N; Mazier, D; Mustière, R; Nguyen, M; Paloque, L; Primas, N; Rault, S; Roques, P; Snounou, G; Soulard, V; Suzanne, P; Tajeri, S; Tefit, M; Vanelle, P; Verhaeghe, P | 1 |
Chen, G; Kaplan, D; Li, G; Liu, P; Wang, X; Wu, Q; Xie, M; Yu, J; Zheng, Z | 1 |
Chen, L; He, SJ; Tong, X; Zuo, JP | 1 |
Hajebrahimi, Z; Noureddini, M; Poorgholam, P; Yaghmaei, P | 1 |
Ciapała, K; Ciechanowska, A; Mika, J; Pawlik, K; Rojewska, E | 1 |
Chen, Z; Li, T; Zhu, X | 1 |
Anderson, TJC; Button-Simons, K; Cheeseman, IH; Emrich, S; Ferdig, MT; Haile, M; Kappe, SHI; Kumar, S; Li, X; McDew-White, M; Nosten, F; Vaughan, AM | 1 |
Cao, Q; Du, H; Duan, N; Fu, X; Li, X; Liu, C | 1 |
Li, S; Liu, L; Silva, M; Xing, X; Zhao, X; Zheng, W | 1 |
Gille, L; Machín, L; Monzote, L; Nápoles, R | 1 |
Ge, W; Huai, M; Zeng, J | 1 |
Bao, Y; Chen, L; Dai, F; Li, Z; Liu, Z; Ma, Y; Peng, Y | 1 |
Çavuş, İ; Kaya, T; Nuraydın, A; Özbilgin, A | 1 |
Dawre, S; Devarajan, PV; Pathak, S; Sharma, S | 1 |
Chookajorn, T | 1 |
Brewer, JM; Lee, RS; Waters, AP | 1 |
Mu, X; Wang, C | 1 |
Cao, Y; Feng, YH; Gao, LW; Jin, F; Jin, QX; Li, XY; Lu, SL; Wang, YY; Wei, MJ; Xu, YY | 1 |
Cao, Q; Du, H; Fu, X; Jiang, Y; Li, X; Liu, X | 1 |
Benoit-Vical, F; Claparols, C; Robert, A; Witkowski, B | 1 |
Bakshi, RP; Nenortas, E; Shapiro, TA; Sullivan, DJ; Tripathi, AK | 1 |
Conyers, RC; Mazzone, JR; Posner, GH; Sullivan, DJ; Tripathi, AK | 1 |
Bhakuni, RS; Chauhan, A; Dhawan, OP; Dhawan, S; Khan, F; Qidwai, T; Sharma, P; Yadav, DK | 1 |
Chatterjee, S; Nodiff, EA; Tanabe, K | 1 |
Chen, J; Dong, L; Duan, W; Qiao, C; Sun, H; Xia, CM | 1 |
Cabral, L; Cristiano, ML; Lobo, L; Nogueira, F; Sousa, Bd | 1 |
Alexander, GR; Chatuverdi, NK; Chen, X; Coulter, DW; Dong, Y; Gray, S; Joshi, SS; McGuire, TR; McIntyre, EM; Sharp, JG; Vennerstrom, JL; Wang, X | 1 |
He, SJ; Lin, ZM; Tang, W; Yang, XQ; Zhu, FH; Zuo, JP | 1 |
Anderson, M; Bayih, AG; Eagon, S; Folefoc, A; Mohon, AN; Pillai, DR | 1 |
Atemnkeng, MA; Chimanuka, B; Dejaegher, B; Heyden, YV; Plaizier-Vercammen, J | 1 |
Gautam, N; Gupta, RC; Sabarinath, S; Singh, RP; Singh, SK | 1 |
Chatterjee, M; Ganguly, S; Saha, P; Sen, R | 1 |
Gros, P; Min-Oo, G | 1 |
An, P; Qiao, CL; Shi, XM; Sun, WS; Wang, Z; Wu, XL; Zhang, WG | 1 |
Bai, SF; Chen, H; Gao, Y; Li, T; Liu, DL; Liu, XG; Mei, X; Wei, N; Zhang, S; Zhou, YX | 1 |
An, P; Qiao, CL; Shi, XM; Sun, WS; Wang, Z; Wu, XL | 1 |
Bell, A | 1 |
Efferth, T | 1 |
Ager, A; Andersen, SL; Berman, J; Ellis, W; Kuschner, R; McGreevy, P; Ohrt, C; Rossan, R; Schuster, BG; Wesche, D | 1 |
Lederman, J; Rosenbaum, GS; Tanowitz, HB; Weiss, LM; Wittner, M | 1 |
Meshnick, SR | 1 |
Jain, GK; Pandey, VC; Puri, SK; Singh, S; Srivastava, P | 1 |
6 review(s) available for artemisinin and Disease Models, Animal
Article | Year |
---|---|
Artemisinin derivative SM934 in the treatment of autoimmune and inflammatory diseases: therapeutic effects and molecular mechanisms.
Topics: Animals; Artemisinins; Autoimmune Diseases; Biological Products; Disease Models, Animal; Water | 2022 |
Artemisinins-a Promising New Treatment for Systemic Lupus Erythematosus: a Descriptive Review.
Topics: Animals; Artemisinins; Artesunate; Disease Models, Animal; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Mice | 2018 |
Genetic analysis in mice identifies cysteamine as a novel partner for artemisinin in the treatment of malaria.
Topics: Amidohydrolases; Animals; Artemisinins; Cysteamine; Disease Models, Animal; Drug Therapy, Combination; GPI-Linked Proteins; Humans; Malaria; Mice; Plasmodium | 2011 |
Antimalarial drug synergism and antagonism: mechanistic and clinical significance.
Topics: Animals; Antimalarials; Artemisinins; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Folic Acid Antagonists; Humans; Malaria; Plasmodium berghei; Plasmodium falciparum; Protease Inhibitors; Quinolines; Sesquiterpenes | 2005 |
Willmar Schwabe Award 2006: antiplasmodial and antitumor activity of artemisinin--from bench to bedside.
Topics: Animals; Antimalarials; Antineoplastic Agents, Phytogenic; Artemisia annua; Artemisinins; Awards and Prizes; Disease Models, Animal; Drug Resistance, Multiple; Humans; Pharmacogenetics; Phytotherapy; Sesquiterpenes | 2007 |
Artemisinin antimalarials: mechanisms of action and resistance.
Topics: Animals; Antimalarials; Artemisinins; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Resistance; Humans; Malaria, Falciparum; Mice; Plasmodium falciparum; Protozoan Proteins; Sesquiterpenes | 1998 |
42 other study(ies) available for artemisinin and Disease Models, Animal
Article | Year |
---|---|
Discovery of a Quinoline-4-carboxamide Derivative with a Novel Mechanism of Action, Multistage Antimalarial Activity, and Potent in Vivo Efficacy.
Topics: Animals; Antimalarials; Disease Models, Animal; Drug Discovery; Malaria; Mice; Molecular Structure; Plasmodium falciparum; Quinolines; Structure-Activity Relationship | 2016 |
Optimization of 2-Anilino 4-Amino Substituted Quinazolines into Potent Antimalarial Agents with Oral in Vivo Activity.
Topics: Administration, Oral; Animals; Antimalarials; Disease Models, Animal; Mice; Plasmodium falciparum; Quinazolines; Structure-Activity Relationship | 2017 |
Antimalarial Activities of Alkyl Cyclohexenone Derivatives Isolated from the Leaves of Poupartia borbonica.
Topics: Anacardiaceae; Animals; Antimalarials; Belgium; Cyclohexanones; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Flavonoids; HeLa Cells; Humans; Inhibitory Concentration 50; Malaria; Mice; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Parasitic Sensitivity Tests; Plant Leaves; Plasmodium berghei; Plasmodium falciparum; Quercetin; Zebrafish | 2017 |
4-Aryl Pyrrolidines as a Novel Class of Orally Efficacious Antimalarial Agents. Part 1: Evaluation of 4-Aryl- N-benzylpyrrolidine-3-carboxamides.
Topics: Administration, Oral; Animals; Antimalarials; Biological Availability; Disease Models, Animal; Drug Evaluation, Preclinical; Malaria; Mice; Microsomes, Liver; Pyrrolidines; Structure-Activity Relationship | 2019 |
Synthesis and structure-activity relationships for new 6-fluoroquinoline derivatives with antiplasmodial activity.
Topics: Animals; Antimalarials; Cell Line; Cell Survival; Disease Models, Animal; Drug Resistance; Malaria; Mice; Parasitic Sensitivity Tests; Plasmodium berghei; Plasmodium falciparum; Quinolines; Structure-Activity Relationship | 2019 |
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
A New Thienopyrimidinone Chemotype Shows Multistage Activity against Plasmodium falciparum, Including Artemisinin-Resistant Parasites.
Topics: Animals; Antimalarials; Artemisinins; Cell Line, Tumor; Disease Models, Animal; Dogs; Drug Resistance; Female; Hep G2 Cells; Humans; Liver; Macaca fascicularis; Madin Darby Canine Kidney Cells; Malaria, Falciparum; Male; Mice; Mice, Inbred BALB C; Plasmodium cynomolgi; Plasmodium falciparum; Plasmodium yoelii; Pyrimidinones | 2021 |
Sustainable Antibacterial and Anti-Inflammatory Silk Suture with Surface Modification of Combined-Therapy Drugs for Surgical Site Infection.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Artemisinins; Berberine; Cell Line; Cell Survival; Coated Materials, Biocompatible; Disease Models, Animal; Drug Liberation; Drug Therapy, Combination; Escherichia coli; Hemolysis; Humans; Male; Physical Phenomena; Rats, Sprague-Dawley; Silk; Staphylococcus aureus; Surgical Wound Infection; Sutures | 2022 |
Artemisin and human endometrial-derived stem cells improve cognitive function and synaptic plasticity in a rat model of Alzheimer disease and diabetes.
Topics: Alzheimer Disease; Animals; Artemisinins; Cognition; Diabetes Mellitus; Disease Models, Animal; Hippocampus; Humans; Long-Term Potentiation; Maze Learning; Neurodegenerative Diseases; Neuronal Plasticity; Rats; Streptozocin; Thrombospondin 1 | 2023 |
Analgesic Effects of Fisetin, Peimine, Astaxanthin, Artemisinin, Bardoxolone Methyl and 740 Y-P and Their Influence on Opioid Analgesia in a Mouse Model of Neuropathic Pain.
Topics: Analgesia; Analgesics; Analgesics, Opioid; Animals; Artemisinins; Disease Models, Animal; Hyperalgesia; Male; Mice; Morphine; Neuralgia; NF-E2-Related Factor 2; NF-kappa B; Oxycodone; Phosphatidylinositol 3-Kinases | 2023 |
[Oral administration of artemisinin nanospheres alleviates inflammation in mice with spontaneous ulcerative colitis].
Topics: Administration, Oral; Animals; Artemisinins; Colitis, Ulcerative; Disease Models, Animal; Inflammation; Mice; Nanospheres; RNA, Messenger | 2023 |
Genetic mapping of fitness determinants across the malaria parasite Plasmodium falciparum life cycle.
Topics: Animals; Anopheles; Antimalarials; Artemisinins; Chromosome Mapping; Disease Models, Animal; Drug Resistance; Female; Gene Frequency; Genetic Loci; Host-Parasite Interactions; Humans; Life Cycle Stages; Malaria, Falciparum; Male; Mice; Mosquito Vectors; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins; Ribosomal Proteins; Selection, Genetic; Transplantation Chimera | 2019 |
Artemisinin Attenuated Atherosclerosis in High-Fat Diet-Fed ApoE-/- Mice by Promoting Macrophage Autophagy Through the AMPK/mTOR/ULK1 Pathway.
Topics: AMP-Activated Protein Kinases; Animals; Anti-Inflammatory Agents; Aorta; Aortic Diseases; Artemisinins; Atherosclerosis; Autophagy; Autophagy-Related Protein-1 Homolog; Diet, High-Fat; Disease Models, Animal; Foam Cells; Lipoproteins, LDL; Male; Mice; Mice, Inbred C57BL; Mice, Knockout, ApoE; Microtubule-Associated Proteins; Phosphorylation; Plaque, Atherosclerotic; RAW 264.7 Cells; Sequestosome-1 Protein; Signal Transduction; TOR Serine-Threonine Kinases | 2020 |
Artemisinin protects motoneurons against axotomy-induced apoptosis through activation of the PKA-Akt signaling pathway and promotes neural stem/progenitor cells differentiation into NeuN
Topics: Animals; Apoptosis; Artemisinins; Axotomy; Behavior, Animal; Brachial Plexus; Cells, Cultured; Cyclic AMP-Dependent Protein Kinases; Disease Models, Animal; DNA-Binding Proteins; Mice, Inbred C57BL; Motor Neurons; Nerve Tissue Proteins; Neural Stem Cells; Neurogenesis; Neuroprotective Agents; Peripheral Nerve Injuries; Phosphorylation; Proto-Oncogene Proteins c-akt; Recovery of Function; Signal Transduction; Spinal Cord | 2020 |
Leishmania amazonensis response to artemisinin and derivatives.
Topics: Animals; Artemether; Artemisinins; Artesunate; Disease Models, Animal; Female; Leishmania mexicana; Mice; Mice, Inbred BALB C; Parasite Load; Trypanocidal Agents | 2021 |
Artemisinin ameliorates intestinal inflammation by skewing macrophages to the M2 phenotype and inhibiting epithelial-mesenchymal transition.
Topics: Animals; Anti-Inflammatory Agents; Artemisinins; Colitis; Colon; Crohn Disease; Cytokines; Dextran Sulfate; Disease Models, Animal; Epithelial-Mesenchymal Transition; Female; Humans; Inflammation Mediators; Macrophages; Mice; Mice, Inbred C57BL; Phenotype; RAW 264.7 Cells; Signal Transduction; Tissue Culture Techniques | 2021 |
Electrospun PLGA/SF/artemisinin composite nanofibrous membranes for wound dressing.
Topics: Animals; Anti-Infective Agents; Artemisinins; Bandages; Cytokines; Delayed-Action Preparations; Disease Models, Animal; Drug Carriers; Drug Compounding; Drug Liberation; Fibroins; Macrophages; Male; Membranes, Artificial; Mice; Nanofibers; Polylactic Acid-Polyglycolic Acid Copolymer; Rats, Sprague-Dawley; RAW 264.7 Cells; Skin; Wound Healing; Wounds, Penetrating | 2021 |
In vivo and in vitro Models for Scanning Drug Substances in Malaria: Prestudy.
Topics: Animals; Antimalarials; Artemisinins; Chloroquine; Disease Models, Animal; Drug Evaluation, Preclinical; In Vitro Techniques; Malaria; Male; Mice; Mice, Inbred BALB C; Plant Extracts; Plasmodium berghei; Tetracycline | 2017 |
Enhanced antimalalarial activity of a prolonged release in situ gel of arteether-lumefantrine in a murine model.
Topics: Animals; Antimalarials; Artemisinins; Chemistry, Pharmaceutical; Delayed-Action Preparations; Disease Models, Animal; Drug Therapy, Combination; Ethanolamines; Fluorenes; Gels; Lumefantrine; Malaria, Falciparum; Male; Mice; Polymers | 2018 |
How to combat emerging artemisinin resistance: Lessons from "The Three Little Pigs".
Topics: Animals; Antimalarials; Artemisinins; Disease Models, Animal; Drug Resistance; Humans; Malaria, Falciparum; Plasmodium falciparum; Public Health; Swine | 2018 |
A cryptic cycle in haematopoietic niches promotes initiation of malaria transmission and evasion of chemotherapy.
Topics: Animals; Antimalarials; Artemisinins; Disease Models, Animal; Drug Resistance; Female; Gametogenesis; Hematopoietic Stem Cells; Humans; Malaria; Mice; Mice, Inbred BALB C; Plasmodium berghei; Reproduction, Asexual; Reticulocytes; Stem Cell Niche | 2018 |
Artemisinin enhances the anti-tumor immune response in 4T1 breast cancer cells in vitro and in vivo.
Topics: Animals; Apoptosis; Artemisinins; Breast Neoplasms; CD4-Positive T-Lymphocytes; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Female; Humans; Immunity, Cellular; Immunization; Interferon-gamma; Lymphocyte Activation; Medicine, Chinese Traditional; Mice; Mice, Inbred BALB C; T-Box Domain Proteins; T-Lymphocytes, Cytotoxic; T-Lymphocytes, Regulatory | 2019 |
Artemisinin alleviates atherosclerotic lesion by reducing macrophage inflammation via regulation of AMPK/NF-κB/NLRP3 inflammasomes pathway.
Topics: AMP-Activated Protein Kinases; Animals; Artemisinins; Atherosclerosis; Cell Culture Techniques; Diet, High-Fat; Disease Models, Animal; Dose-Response Relationship, Drug; Inflammasomes; Inflammation; Inflammation Mediators; Macrophages; Male; Mice; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein | 2020 |
Correlation between Plasmodium yoelii nigeriensis susceptibility to artemisinin and alkylation of heme by the drug.
Topics: Alkylation; Animals; Antimalarials; Artemisinins; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Resistance; Erythrocytes; Female; Heme; Malaria; Mice; Plasmodium yoelii; Protein Binding; Spleen | 2013 |
Model system to define pharmacokinetic requirements for antimalarial drug efficacy.
Topics: Animals; Antimalarials; Artemisinins; Chloroquine; Disease Models, Animal; Humans; Malaria, Falciparum; Mice; Mice, Inbred C57BL; Models, Biological; Parasitic Sensitivity Tests; Plasmodium berghei; Plasmodium falciparum; Reproducibility of Results; Treatment Outcome | 2013 |
Antimalarial chemotherapy: artemisinin-derived dimer carbonates and thiocarbonates.
Topics: Animals; Antimalarials; Artemisinins; Carbonates; Dimerization; Disease Models, Animal; Dose-Response Relationship, Drug; Malaria; Male; Mice; Mice, Inbred C57BL; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium berghei; Structure-Activity Relationship; Sulfhydryl Compounds | 2014 |
QSAR and docking based semi-synthesis and in vivo evaluation of artemisinin derivatives for antimalarial activity.
Topics: Animals; Antimalarials; Artemisinins; Aspartic Acid Endopeptidases; Binding Sites; Biological Availability; Computer-Aided Design; Disease Models, Animal; Drug Design; Magnetic Resonance Spectroscopy; Malaria; Mice; Molecular Docking Simulation; Plasmodium yoelii; Protozoan Proteins; Quantitative Structure-Activity Relationship | 2014 |
In search of next generation antimalarials.
Topics: Animals; Antimalarials; Artemisinins; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Discovery; Macaca mulatta; Malaria; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium; Structure-Activity Relationship | 2014 |
An artemisinin derivative of praziquantel as an orally active antischistosomal agent.
Topics: Administration, Oral; Animals; Artemisinins; Disease Models, Animal; Female; Mice; Mice, Inbred ICR; Praziquantel; Schistosomiasis japonica; Schistosomicides | 2014 |
Highly active ozonides selected against drug resistant malaria.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Chloroquine; Disease Models, Animal; Female; Humans; Malaria, Falciparum; Mefloquine; Mice; Parasitemia; Plasmodium falciparum | 2016 |
Treatment of a chemoresistant neuroblastoma cell line with the antimalarial ozonide OZ513.
Topics: Animals; Antimalarials; Antineoplastic Agents; Apoptosis; Artemisinins; Biomarkers; Caspase 3; Cell Cycle; Cell Line, Tumor; Disease Models, Animal; Drug Resistance, Neoplasm; Heterocyclic Compounds; Humans; Metabolome; Metabolomics; Mice; Neuroblastoma; Xenograft Model Antitumor Assays | 2016 |
Artemisinin analogue SM934 attenuate collagen-induced arthritis by suppressing T follicular helper cells and T helper 17 cells.
Topics: Animals; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Cattle; CD4-Positive T-Lymphocytes; Collagen Type II; Disease Models, Animal; Female; Interferon-gamma; Interleukins; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; Proto-Oncogene Proteins c-bcl-6; STAT3 Transcription Factor; Th17 Cells | 2016 |
In vitro and in vivo anti-malarial activity of novel harmine-analog heat shock protein 90 inhibitors: a possible partner for artemisinin.
Topics: Animals; Antimalarials; Artemisinins; Cell Line; Cell Survival; Disease Models, Animal; Drug Synergism; Female; Harmine; HSP90 Heat-Shock Proteins; Humans; Inhibitory Concentration 50; Malaria; Mice, Inbred BALB C; Plasmodium berghei; Plasmodium falciparum; Protein Binding; Protozoan Proteins; Treatment Outcome | 2016 |
Evaluation of Artemisia annua infusion efficacy for the treatment of malaria in Plasmodium chabaudi chabaudi infected mice.
Topics: Animals; Anti-Infective Agents; Artemisia annua; Artemisinins; Beverages; Chromatography, Thin Layer; Densitometry; Disease Models, Animal; Female; Malaria; Mice; Parasitemia; Phytotherapy; Plant Leaves; Plasmodium chabaudi | 2009 |
Liquid chromatographic tandem mass spectrometric assay for quantification of 97/78 and its metabolite 97/63: a promising trioxane antimalarial in monkey plasma.
Topics: Animals; Antimalarials; Artemisinins; Chromatography, Liquid; Disease Models, Animal; Humans; Macaca mulatta; Malaria; Male; Tandem Mass Spectrometry | 2009 |
Efficacy of artemisinin in experimental visceral leishmaniasis.
Topics: Animals; Antiprotozoal Agents; Artemisinins; Disease Models, Animal; Humans; Inhibitory Concentration 50; Leishmania donovani; Leishmaniasis, Visceral; Macrophages; Mice; Mice, Inbred BALB C; Parasitic Sensitivity Tests; Spleen; Treatment Outcome | 2010 |
Effect of artemisinin combined with glucocorticoid on the expressions of glucocorticoid receptor α mRNA, glucocorticoid receptor β mRNA and P300/CBP protein in lupus nephritis mice.
Topics: Animals; Artemisinins; Base Sequence; Disease Models, Animal; DNA Primers; Electrophoresis, Agar Gel; Female; Lupus Nephritis; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; p300-CBP Transcription Factors; Prednisone; Receptors, Glucocorticoid; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2011 |
Anti-inflammatory and immunomodulatory mechanisms of artemisinin on contact hypersensitivity.
Topics: Animals; Anti-Inflammatory Agents; Artemisinins; Concanavalin A; Cytokines; Dermatitis, Contact; Dinitrofluorobenzene; Disease Models, Animal; Female; Immunologic Factors; Irritants; Lymph Nodes; Mice; Mice, Inbred BALB C; Mitogens; Organ Size; Phytotherapy; Spleen; T-Lymphocytes, Regulatory; Th17 Cells | 2012 |
[Effect of artemisinin on the expressions of GRalpha mRNA, GRbeta mRNA and P300/CBP protein in lupus nephritis mice].
Topics: Animals; Artemisia annua; Artemisinins; Disease Models, Animal; Female; Leukocytes, Mononuclear; Lupus Nephritis; Mice; Mice, Inbred Strains; p300-CBP Transcription Factors; Prednisone; Receptors, Glucocorticoid; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2012 |
Activity of azithromycin as a blood schizonticide against rodent and human plasmodia in vivo.
Topics: Administration, Oral; Animals; Antimalarials; Aotus trivirgatus; Artemisinins; Azithromycin; Disease Models, Animal; Doxycycline; Drug Therapy, Combination; Humans; Injections, Subcutaneous; Malaria; Malaria, Falciparum; Mice; Parasitemia; Phenanthrenes; Plasmodium berghei; Quinine; Sesquiterpenes | 1995 |
Atovaquone in the treatment of Babesia microti infections in hamsters.
Topics: Animals; Anti-Bacterial Agents; Antimalarials; Antiprotozoal Agents; Artemisinins; Atovaquone; Azithromycin; Babesiosis; Cricetinae; Disease Models, Animal; Drug Therapy, Combination; Naphthoquinones; Parasitemia; Recurrence; Sesquiterpenes | 1996 |
A simple and rapid evaluation of methemoglobin toxicity of 8-aminoquinolines and related compounds.
Topics: Administration, Cutaneous; Administration, Oral; Aminoquinolines; Animals; Antimalarials; Artemisinins; Cell-Free System; Chloroquine; Cytochrome-B(5) Reductase; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Erythrocytes; Macaca mulatta; Methemoglobin; Methemoglobinemia; Muridae; Oxyhemoglobins; Primaquine; Rats; Sesquiterpenes | 2000 |